1. Home
  2. CFR vs RGEN Comparison

CFR vs RGEN Comparison

Compare CFR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullen/Frost Bankers Inc.

CFR

Cullen/Frost Bankers Inc.

HOLD

Current Price

$163.98

Market Cap

10.3B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$181.91

Market Cap

6.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CFR
RGEN
Founded
1868
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
6.6B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
CFR
RGEN
Price
$163.98
$181.91
Analyst Decision
Hold
Buy
Analyst Count
13
12
Target Price
$142.31
$167.67
AVG Volume (30 Days)
572.8K
1.2M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
2.80%
N/A
EPS Growth
11.84
286.96
EPS
5.35
0.24
Revenue
$2,235,244,000.00
$141,236,000.00
Revenue This Year
$9.72
$14.30
Revenue Next Year
$4.70
$14.52
P/E Ratio
$30.81
$751.21
Revenue Growth
8.31
35.10
52 Week Low
$119.00
$100.99
52 Week High
$170.80
$188.73

Technical Indicators

Market Signals
Indicator
CFR
RGEN
Relative Strength Index (RSI) 50.41 76.48
Support Level $162.32 $156.65
Resistance Level $170.29 N/A
Average True Range (ATR) 2.87 6.79
MACD -0.86 1.81
Stochastic Oscillator 21.82 84.69

Price Performance

Historical Comparison
CFR
RGEN

About CFR Cullen/Frost Bankers Inc.

Cullen/Frost is a regional US bank with around $52 billion in assets (as of March 2026), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based banking approach that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through targeted branch openings rather than acquisitions. The bank's sweet spot is small to medium-sized Texas-based commercial clients.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: